Therapies are going to find their home in the realm of brain tumor awareness, which is something that very few individuals will be able to argue against. There will be procedures that will come about and it seems as though various drugs will make sure that this happens in the long term. That being said, what can be said about the ICT-107 vaccine? To me, this is something that can prove useful, if a specific recent report is to be taken into account in the long term.
An article on Medical News Today went into detail about this particular matter and I do not think that it is hard to see why. Keep in mind that glioblastoma multiforme is the condition being targeted here, which is something that can be said about most other procedures related to brain tumor awareness. The level of aggression seen in this particular condition is something that no other tumor type can match. As a result, organizations along the lines of Voices against Brain Cancer are going to focus on it.
When it comes to the cells that are involved in this particular condition, regeneration seems to come about rather quickly. This is due, at least to some degree, to the blood stream that seems to be rather constant within the body. This is a point that the American Brain Tumor Association went into detail about. In addition, it was said that the risk of the condition increases with age - especially with men - but it seems like it can come about in anyone, regardless of factors like age or gender.
A study that was done by the Cedars-Sinai Medical Group was one that was able to put the ICT-107 vaccine to use. This would be able to benefit the immune system, as it would direct attention to the cancerous cells within the body. After this was done, a tumor-killing response would follow. Keep in mind that this vaccine is administered only after the typical conditions are met, invasive surgery, chemo, and radiation included. After the vaccine was brought into play three times week at two-week intervals, results would be had.
I think that these particular results were quite positive, as it seems like seven of the sixteen patients that were originally involved could be helped that much more in the long term. Survival rates extended between 60.7 and 82.7 months, which is great for those who consistently bring attention to the matter. In addition, take into account that six of the original patients were said to be "progression-free." They did not have to worry about tumors coming back and the fact that treatment did not have to be followed up on speaks greater volumes.
An article on Medical News Today went into detail about this particular matter and I do not think that it is hard to see why. Keep in mind that glioblastoma multiforme is the condition being targeted here, which is something that can be said about most other procedures related to brain tumor awareness. The level of aggression seen in this particular condition is something that no other tumor type can match. As a result, organizations along the lines of Voices against Brain Cancer are going to focus on it.
When it comes to the cells that are involved in this particular condition, regeneration seems to come about rather quickly. This is due, at least to some degree, to the blood stream that seems to be rather constant within the body. This is a point that the American Brain Tumor Association went into detail about. In addition, it was said that the risk of the condition increases with age - especially with men - but it seems like it can come about in anyone, regardless of factors like age or gender.
A study that was done by the Cedars-Sinai Medical Group was one that was able to put the ICT-107 vaccine to use. This would be able to benefit the immune system, as it would direct attention to the cancerous cells within the body. After this was done, a tumor-killing response would follow. Keep in mind that this vaccine is administered only after the typical conditions are met, invasive surgery, chemo, and radiation included. After the vaccine was brought into play three times week at two-week intervals, results would be had.
I think that these particular results were quite positive, as it seems like seven of the sixteen patients that were originally involved could be helped that much more in the long term. Survival rates extended between 60.7 and 82.7 months, which is great for those who consistently bring attention to the matter. In addition, take into account that six of the original patients were said to be "progression-free." They did not have to worry about tumors coming back and the fact that treatment did not have to be followed up on speaks greater volumes.
About the Author:
Visit Voices Against Brain Cancer if you're seeking some additional information about brain tumor research and awareness.. Check here for free reprint license: The ICT-107 Vaccine For Brain Tumor Awareness.
No comments:
Post a Comment